peripheral T-cell lymphomas (PTCL)

March 5, 2020March 5, 2020

Tipifarnib Granted FDA Fast Track Designation for T-cell Lymphomas

News

Kura Oncology‘s investigational lead therapy candidate tipifarnib was given fast track status by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with different subtypes of ... Read more

December 12, 2019December 12, 2019

Health Canada Approves Adcetris-Chemo Combo for Initial Peripheral T-cell Lymphoma Treatment

News

Health Canada has expanded its approval of Adcetris (brentuximab vedotin) in combination with a chemotherapy regimen for the first-line treatment of peripheral T-cell lymphomas expressing the CD30 marker. The approval is ... Read more

January 30, 2019

Baseline and Interim PET Scans May Predict Long-Term Survival of PTCL Patients, Study Shows

News

Higher tumor volume at baseline and worse responses to chemotherapy after four cycles — measured with positron emission tomography (PET) scans — can predict poorer overall and event-free survival among ... Read more

September 20, 2018

Older Stem Cell Transplant Patients with Non-Hodgkin’s Lymphoma at Higher Risk of Death, Study Suggests

News

Stem cell transplant to treat non-Hodgkin’s lymphoma in patients older than 65 is as effective as it is in younger patients, but is associated with a higher risk of non-relapse ... Read more